These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2997827)

  • 1. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
    Hine B
    Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
    Bloom AS; Dewey WL
    Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.
    Tulunay FC; Ayhan IH; Sparber SB
    Psychopharmacology (Berl); 1982; 78(4):358-60. PubMed ID: 6296906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
    Welch SP; Stevens DL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):10-8. PubMed ID: 1320680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.
    Vela G; Fuentes JA; Bonnin A; Fernández-Ruiz J; Ruiz-Gayo M
    Brain Res; 1995 May; 680(1-2):142-7. PubMed ID: 7663970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
    Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
    Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
    Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to morphine bradycardia in the rat.
    Kiang JG; Dewey WL; Wei ET
    J Pharmacol Exp Ther; 1983 Jul; 226(1):187-91. PubMed ID: 6864538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinctive antinociceptive systems in rats with pathological pain.
    Mao J; Price DD; Lu J; Keniston L; Mayer DJ
    Neurosci Lett; 2000 Feb; 280(1):13-6. PubMed ID: 10696800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.
    Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jul; 260(1):5-13. PubMed ID: 7957626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
    Kawasaki H; Watanabe S; Ueki S
    Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.
    Manwell LA; Mallet PE
    Psychopharmacology (Berl); 2015 May; 232(9):1655-65. PubMed ID: 25395060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
    Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
    Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.